ABT
Abbott Laboratories
Healthcare
$87.77
as of May 21, 2026
Sign in to add ABT to your portfolio.
Sign inMarket cap
$153.91B
P/E (TTM)
24.6x
EPS (TTM)
$3.59
Dividend yield
2.76%
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $43.08B | $7.07B | $8.65B | 53.9% | 21.4% | $3.97 |
| 2022 | $43.65B | $6.93B | $7.80B | 51.1% | 19.2% | $3.94 |
| 2023 | $40.11B | $5.72B | $5.06B | 50.0% | 16.0% | $3.30 |
| 2024 | $41.95B | $13.40B | $6.35B | 50.8% | 16.3% | $7.67 |
| 2025 | $44.33B | $6.52B | $7.39B | 55.5% | 18.2% | $3.74 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $88.60 | $87.77 | 8.52M |
| May 20, 2026 | $88.20 | $88.38 | 7.83M |
| May 19, 2026 | $88.36 | $88.82 | 11.69M |
| May 18, 2026 | $84.86 | $87.91 | 12.34M |
| May 15, 2026 | $85.89 | $84.47 | 13.21M |
| May 14, 2026 | $84.18 | $84.90 | 11.02M |
| May 13, 2026 | $83.40 | $83.83 | 11.83M |
| May 12, 2026 | $83.42 | $84.35 | 16.39M |
| May 11, 2026 | $84.44 | $82.56 | 16.46M |
| May 08, 2026 | $87.16 | $84.32 | 10.91M |
| May 07, 2026 | $86.32 | $87.01 | 13.27M |
| May 06, 2026 | $87.55 | $86.30 | 12.46M |
| May 05, 2026 | $87.31 | $87.17 | 17.19M |
| May 04, 2026 | $89.18 | $87.54 | 14.72M |
| May 01, 2026 | $91.00 | $89.46 | 12.86M |
| Apr 30, 2026 | $91.48 | $90.79 | 19.66M |
| Apr 29, 2026 | $93.65 | $91.33 | 9.01M |
| Apr 28, 2026 | $93.84 | $93.86 | 11.55M |
| Apr 27, 2026 | $91.62 | $92.80 | 15.20M |
| Apr 24, 2026 | $92.15 | $91.13 | 12.80M |
| Apr 23, 2026 | $91.61 | $92.48 | 13.01M |
| Apr 22, 2026 | $92.62 | $91.70 | 11.98M |
| Apr 21, 2026 | $95.60 | $92.72 | 17.16M |
| Apr 20, 2026 | $96.50 | $96.00 | 9.41M |
Profitability & balance
- ROE (TTM)
- 12.2%
- Gross margin
- 56.4%
- Operating margin
- 18.2%
- Net margin
- 13.9%
- Debt / equity
- 0.65